Keyphrases
Oral Candidiasis
90%
AIDS/HIV
85%
Surabaya
61%
AIDS Patients
50%
Candida Species
37%
Candida Albicans (C. albicans)
37%
Fluconazole
37%
Outpatient Clinic
34%
Nystatin
34%
Indonesia
30%
Antifungal Activity
27%
HIV Patients
27%
Candida
27%
Academic Hospital
26%
Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome
25%
C.albicans
18%
Vulvovaginal Candidiasis
18%
High-risk Human Papillomavirus (HR-HPV)
18%
Condyloma Acuminatum
18%
Crusted Scabies
18%
Vitiligo
18%
Neutrophil-to-lymphocyte Ratio
18%
Erythema Nodosum Leprosum
18%
Rosemary Essential Oil
16%
CD4 Count
16%
Scabies
15%
Rosmarinus Officinalis
14%
Human Immunodeficiency Virus Infection
12%
Immunohistochemistry
12%
Platelet-to-lymphocyte Ratio
12%
Sexually Transmitted Infections
12%
Syphilis Serology
12%
Non-albicans
12%
Titer
12%
Effective Treatment
11%
Bacterial Vaginosis
11%
Ketoconazole
11%
Benzathine Penicillin
11%
Secondary Syphilis
11%
Secondary Infection
11%
Mites
11%
Antifungal Effect
11%
Dermatovenerology
11%
Essential Oil
11%
Teaching Hospital
11%
Academic Teaching
11%
Rosemary
10%
Quality of Life
10%
Underlying Disease
10%
Fluconazole Resistance
10%
Pharmacology, Toxicology and Pharmaceutical Science
Thrush
100%
HIV
98%
Candida
88%
Nystatin
52%
Candida Albicans
40%
Antifungal Activity
37%
Fluconazole
34%
Acquired Immune Deficiency Syndrome
27%
Rosemary
27%
Essential Oil
20%
Retrospective Study
19%
Epigallocatechin Gallate
18%
Basil
18%
Eugenol
18%
Psoriasis Vulgaris
18%
Infection
16%
Ocimum Sanctum Extract
14%
Vaginitis
12%
Ketoconazole
11%
Clinical Feature
10%
Gonorrhea
9%
Lactobacillus plantarum
9%
Placebo
9%
Juvenile Dermatomyositis
9%
Contraceptive Agent
9%
Human Immunodeficiency Virus Infection
9%
Diabetes Mellitus
9%
Uterine Cervicitis
9%
Leukorrhea
9%
Chickenpox
9%
Monkeypox
9%
Condyloma acuminatum
9%
Human Papillomavirus
9%
Controlled Clinical Trial
9%
Retinoic Acid
9%
Acute Kidney Failure
9%
Photoaging
9%
Metronidazole
9%
Syndrome
9%
Vagina Candidiasis
9%
Acne Vulgaris
9%
Onychomycosis
9%
Antifungal Agent
8%
Randomized Controlled Trial
6%
Adjuvant
6%
Medicine and Dentistry
Retrospective Study
57%
Human Immunodeficiency Virus
37%
Outpatient
33%
Diseases
20%
Scabies
18%
Oral Candidiasis
18%
Vitiligo
18%
Vagina Candidiasis
18%
Skin Tumor
18%
Psoriasis Vulgaris
18%
Syphilis
17%
Histopathology
17%
Dermatology
13%
Division
13%
Quality of Life
13%
Single Drug Dose
12%
Dermatology Life Quality Index
12%
Secondary Infection
12%
Infection
12%
Diagnosis
12%
Platelet
12%
Clinical Feature
11%
Neutrophil
11%
HIV/AIDS
11%
Secondary Syphilis
11%
Benzathine Benzylpenicillin
11%
Combination Therapy
11%
Bacterial Infection
10%
Fluconazole
10%
Lymphocyte
10%
Trichomoniasis
10%
Multibacillary Leprosy
10%
Syphilis Serology
10%
Tretinoin
9%
Melanocyte
9%
S-100 Protein
9%
Chloasma
9%
Erythema Nodosum
9%
Monotherapy
9%
Calciphylaxis
9%
Triamcinolone
9%
Uterine Cervicitis
9%
Cosmetics
9%
Self Esteem
9%
Photoaging
9%
Amniotic Stem Cell
9%
Head Lice Infestation
9%
Keloid
9%
Leukorrhea
9%
Erythema Multiforme
9%